Biotest AG - Company Profile

Powered by

All the data and insights you need on Biotest AG in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Biotest AG Strategy Report

  • Understand Biotest AG position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Biotest AG: Overview

Select Item

Biotest AG (Biotest), a subsidiary of Grifols SA, provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products include clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, haematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East, and Africa. It has subsidiaries and sales companies in Austria, Switzerland, France, Great Britain, Italy, Hungary and Spain and Brazil. Biotest is headquartered in Dreieich, Hessen, Germany.

 Gain a 360-degree view of Biotest AG and make more informed decisions for your business Gain a 360-degree view of Biotest AG and make more informed decisions for your business Find out more
Headquarters Germany
Address Landsteinerstr. 5, Dreieich, Hessen, 63303
Website www.biotest.com
Telephone 49 6103 8010
No of Employees 2,426
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange BIO (ETR)
Revenue (2022) $740.3M 32.6% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 501.9% (2022 vs 2021)
Market Cap* $1.5B
Net Profit Margin (2022) XYZ 403.1% (2022 vs 2021)
* As of and is in US$
View Biotest AG financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Biotest AG premium industry data and analytics

50+

Clinical Trials

Determine Biotest AG go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Catalyst Calendar

Proactively evaluate Biotest AG’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

13+

Pipeline Drugs

Identify which of Biotest AG’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

12+

Marketed Drugs

Understand Biotest AG’s commercialized product portfolio to stay one step ahead of the market.

6

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Biotest AG’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Pharmaceuticals: Haemonine
Plasma Proteins Haemoctin
Immunoglobins Cytotect
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Biotest AG portfolio and identify potential areas for collaboration Understand Biotest AG portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Corporate Changes/Expansions In January, the company opened its 11th plasma collection center in Cologne, Germany.
2023 Others In December, the company expanded its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP).
2023 Contracts/Agreements In April, the company strengthened its partnership with Grifols S.A. in the field of research & development, manufacturing, operations as well as sales and distribution.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Biotest AG Takeda Pharmaceutical Co Ltd Celltrion Inc Halozyme Therapeutics Inc Stratec SE
Headquarters Germany Japan South Korea United States of America Germany
City Dreieich Chuo-Ku Incheon San Diego Birkenfeld
State/Province Hessen Tokyo - California Rheinland-Pfalz
No. of Employees 2,426 49,095 1,074 373 1,522
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Michael Ramroth, Ph.D. Chief Executive Officer Senior Management - 62
Ainhoa Mendizabal Chief Financial Officer Senior Management 2023 51
Peter Janssen Chief Operating Officer Senior Management 2022 57
Jorg Schuttrumpf Chief Scientific Officer Senior Management 2022 49
Bernhard Ehmer Chairman Non Executive Board 2022 68
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Biotest AG key executives to enhance your sales strategy Gain insight into Biotest AG key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward